Apyx Medical Corp. (APYX) Tops Q2 EPS by 18c
Tweet
Share
E-mailGet Alerts APYX Hot Sheet
Join SI Premium – FREE
Apyx Medical Corp. (NASDAQ: APYX) reported Q2 EPS of $0.09, $0.18 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.69 million.
For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
